Utah Medical Products Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Utah Medical Products şirketinin toplam hissedar öz sermayesi $124.2M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $129.7M ve $5.5M dir. Utah Medical Products 'in FAVÖK'ü $17.1M faiz karşılama oranı -4.7 dur. Şirketin $88.5M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	-4.7x
Nakit	US$88.45m
Eşitlik	US$124.20m
Toplam yükümlülükler	US$5.50m
Toplam varlıklar	US$129.69m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: UTMD 'nin kısa vadeli varlıkları ( $101.7M ) kısa vadeli yükümlülüklerini ( $3.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: UTMD şirketinin kısa vadeli varlıkları ( $101.7M ) uzun vadeli yükümlülüklerini ( $2.1M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: UTMD borçsuzdur.

Borcun Azaltılması: UTMD un 5 yıl önce borcu yoktu.

Borç Kapsamı: UTMD un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: UTMD şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Utah Medical Products Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Utah Medical Products, Inc. Appoints Carrie Leigh to Its Board of Directors

Third quarter 2024 earnings released: EPS: US$1.03 (vs US$1.08 in 3Q 2023)

Upcoming dividend of US$0.30 per share

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Upcoming dividend of US$0.30 per share

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Second quarter 2021 earnings released: EPS US$0.94 (vs US$0.36 in 2Q 2020)

Upcoming dividend of US$0.28 per share

First quarter 2021 earnings released: EPS US$0.83 (vs US$0.85 in 1Q 2020)

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation